Cadrenal Therapeutics, Inc. CVKD
We take great care to ensure that the data presented and summarized in this overview for Cadrenal Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CVKD
Top Purchases
Top Sells
About CVKD
Insider Transactions at CVKD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,315
-0.67%
|
$17,095
$13.99 P/Share
|
|
Oct 27
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-15.34%
|
$23,400
$13.99 P/Share
|
|
Oct 24
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,129
-0.57%
|
$15,806
$14.03 P/Share
|
|
Oct 24
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-13.3%
|
$23,400
$13.99 P/Share
|
|
Oct 13
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,800
-0.9%
|
$25,200
$14.15 P/Share
|
|
Oct 13
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,800
-11.74%
|
$25,200
$14.07 P/Share
|
|
Oct 09
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,800
-0.89%
|
$25,200
$14.02 P/Share
|
|
Oct 09
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,693
-9.94%
|
$22,009
$13.99 P/Share
|
|
Oct 06
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
107
-0.62%
|
$1,391
$13.99 P/Share
|
|
Oct 02
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
500
-0.25%
|
$7,000
$14.13 P/Share
|
|
Oct 01
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
881
-0.43%
|
$12,334
$14.01 P/Share
|
|
Oct 01
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,700
-9.03%
|
$22,100
$13.99 P/Share
|
|
Sep 29
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
419
-0.21%
|
$5,866
$14.01 P/Share
|
|
Sep 29
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.53%
|
$1,400
$14.0 P/Share
|
|
Sep 25
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
6,790
-3.22%
|
$95,060
$14.09 P/Share
|
|
Sep 25
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,900
-36.54%
|
$152,600
$14.05 P/Share
|
|
Sep 24
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
2,581
-1.21%
|
$33,553
$13.99 P/Share
|
|
Sep 24
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,500
-4.79%
|
$21,000
$14.0 P/Share
|
|
Aug 28
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,193
-0.56%
|
$15,509
$13.99 P/Share
|
|
Aug 28
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
400
-1.26%
|
$5,600
$14.0 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
45.6K
Shares
From
2
Insiders
| Open market or private sale | 45.6K shares |
|---|